At a Glance
Arunjyoti Bio Ventures (ABVL) just pulled off a small miracle – Q1 FY26 revenue of ₹8.7 Cr (+40% QoQ) and a net profit of ₹2.36 Cr after several loss-making quarters. But don’t pop the champagne: margins swing wildly, the ROE is still negative (-11%), and promoter holding looks like a game of musical chairs. At ₹5.94, the stock trades at 3.4x book, screaming “speculative bet.”
Introduction
ABVL’s history is spicier than its financials. Born in 1986, it has dabbled in everything – portfolio management, software, fertilizers, and now FMCG and co-packing for MNCs. Think of it as the jack of all trades, master of… still figuring out. Q1 FY26 offers hope, but sustainability remains the elephant in the boardroom.
Business Model (WTF Do They Even Do?)
- Current Core: Co-packing FMCG & beverages for MNCs.
- Legacy Lines: Bio-pesticides, fertilizers, agri-inputs.
- Past Avatars: Trading, wealth management, software.
Essentially, ABVL rents out its facilities to bigger brands while trying to revive its agro and FMCG verticals. Good move, but scale is the missing ingredient.
Financials Overview
Q1 FY26
- Revenue: ₹8.71 Cr (+39.6% YoY)
- Operating Profit: ₹3.6 Cr (OPM 41%)
- Net Profit: ₹2.36 Cr (vs -₹1.99 Cr Q4)
- EPS: ₹0.13
FY25 Snapshot
- Revenue: ₹27.9 Cr
- PAT: -₹1.16 Cr
- OPM: 19%
Commentary: Profit is up, but volatility makes investors sweat.
Valuation
- P/E: Not meaningful (loss-making FY25)
- CMP/BV: 3.4x → overvalued for its size
- DCF: Not applicable (cash flows erratic)
Fair Value Range: ₹3 – ₹5
CMP ₹5.9 → priced for perfection
